# Archer Aviation Inc.: financial statements, quarterly

ACHR · NYSE · CIK 1824502 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/achr.md) · [Financials](/companies/achr/financials.md) · [Filings](/companies/achr/filings.md) · [Insiders](/companies/achr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/achr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001824502-26-000038.md) | [0.0](/filings/0001824502-26-000059.md) | not reported | not reported | [1.6](/filings/0001824502-26-000038.md) | [5.0](/filings/0001824502-26-000059.md) |
| Research and development | $m | [67.8](/filings/0001628280-24-046438.md) | [79.5 d](/filings/0001824502-26-000019.md) | [83.5](/filings/0001628280-25-024755.md) | [89.8](/filings/0001628280-25-039622.md) | [89.8](/filings/0001824502-25-000010.md) | [94.6 d](/filings/0001824502-26-000019.md) | [104](/filings/0001824502-26-000038.md) | [122](/filings/0001824502-26-000059.md) | [121](/filings/0001824502-25-000010.md) | [147 d](/filings/0001824502-26-000019.md) | [172](/filings/0001824502-26-000038.md) | [186](/filings/0001824502-26-000059.md) |
| Operating income | $m | [(46.2)](/filings/0001628280-24-046438.md) | [(107) d](/filings/0001824502-26-000019.md) | [(142)](/filings/0001628280-25-024755.md) | [(121)](/filings/0001628280-25-039622.md) | [(122)](/filings/0001824502-25-000010.md) | [(124) d](/filings/0001824502-26-000019.md) | [(144)](/filings/0001824502-26-000038.md) | [(176)](/filings/0001824502-26-000059.md) | [(175)](/filings/0001824502-25-000010.md) | [(234) d](/filings/0001824502-26-000019.md) | [(255)](/filings/0001824502-26-000038.md) | [(279)](/filings/0001824502-26-000059.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.1](/filings/0001628280-24-046438.md) | [0.2 d](/filings/0001824502-26-000019.md) | [0.2](/filings/0001628280-25-024755.md) | [0.1](/filings/0001628280-25-039622.md) | [0.1](/filings/0001824502-25-000010.md) | [(0.2) d](/filings/0001824502-26-000019.md) | [0.1](/filings/0001824502-26-000038.md) | [0.1](/filings/0001824502-26-000059.md) | [0.1](/filings/0001824502-25-000010.md) | [0.0 d](/filings/0001824502-26-000019.md) | [0.1](/filings/0001824502-26-000038.md) | [0.0](/filings/0001824502-26-000059.md) |
| Net income | $m | [(51.6)](/filings/0001628280-24-046438.md) | [(109) d](/filings/0001824502-26-000019.md) | [(117)](/filings/0001824502-25-000010.md) | [(107)](/filings/0001824502-25-000010.md) | [(115)](/filings/0001824502-25-000010.md) | [(198) d](/filings/0001824502-26-000019.md) | [(93.4)](/filings/0001824502-26-000038.md) | [(206)](/filings/0001824502-26-000059.md) | [(130)](/filings/0001824502-25-000010.md) | [(189) d](/filings/0001824502-26-000019.md) | [(218)](/filings/0001824502-26-000038.md) | [(263)](/filings/0001824502-26-000059.md) |
| Diluted EPS | $ per share | [(0.19)](/filings/0001628280-24-046438.md) | not reported | [(0.36)](/filings/0001628280-25-024755.md) | [(0.32)](/filings/0001628280-25-039622.md) | [(0.29)](/filings/0001824502-25-000010.md) | not reported | [(0.17)](/filings/0001824502-26-000038.md) | [(0.36)](/filings/0001824502-26-000059.md) | [(0.20)](/filings/0001824502-25-000010.md) | not reported | [(0.28)](/filings/0001824502-26-000038.md) | [(0.34)](/filings/0001824502-26-000059.md) |
| Basic EPS | $ per share | [(0.19)](/filings/0001628280-24-046438.md) | not reported | [(0.36)](/filings/0001628280-25-024755.md) | [(0.32)](/filings/0001628280-25-039622.md) | [(0.29)](/filings/0001824502-25-000010.md) | not reported | [(0.17)](/filings/0001824502-26-000038.md) | [(0.36)](/filings/0001824502-26-000059.md) | [(0.20)](/filings/0001824502-25-000010.md) | not reported | [(0.28)](/filings/0001824502-26-000038.md) | [(0.34)](/filings/0001824502-26-000059.md) |

- Revenue: us-gaap:Revenues
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [461](/filings/0001628280-23-038275.md) | [465](/filings/0001628280-25-008823.md) | [406](/filings/0001628280-24-022240.md) | [360](/filings/0001628280-24-036279.md) | [502](/filings/0001628280-24-046438.md) | [835](/filings/0001824502-26-000019.md) | [1,030](/filings/0001628280-25-024755.md) | [1,724](/filings/0001628280-25-039622.md) | [596](/filings/0001824502-25-000010.md) | [1,022](/filings/0001824502-26-000059.md) | [951](/filings/0001824502-26-000038.md) | [853](/filings/0001824502-26-000059.md) |
| Current assets | $m | [476](/filings/0001628280-23-038275.md) | [480](/filings/0001628280-25-008823.md) | [422](/filings/0001628280-24-022240.md) | [375](/filings/0001628280-24-036279.md) | [523](/filings/0001628280-24-046438.md) | [858](/filings/0001824502-26-000019.md) | [1,065](/filings/0001628280-25-024755.md) | [1,757](/filings/0001628280-25-039622.md) | [1,692](/filings/0001824502-25-000010.md) | [2,076](/filings/0001824502-26-000059.md) | [1,900](/filings/0001824502-26-000038.md) | [1,647](/filings/0001824502-26-000059.md) |
| Total assets | $m | [540](/filings/0001628280-23-038275.md) | [554](/filings/0001628280-25-008823.md) | [511](/filings/0001628280-24-022240.md) | [484](/filings/0001628280-24-036279.md) | [652](/filings/0001628280-24-046438.md) | [1,001](/filings/0001824502-26-000019.md) | [1,215](/filings/0001628280-25-024755.md) | [1,938](/filings/0001628280-25-039622.md) | [1,900](/filings/0001824502-25-000010.md) | [2,466](/filings/0001824502-26-000059.md) | [2,323](/filings/0001824502-26-000038.md) | [2,214](/filings/0001824502-26-000059.md) |
| Current liabilities | $m | [117](/filings/0001628280-23-038275.md) | [114](/filings/0001628280-25-008823.md) | [70.2](/filings/0001628280-24-022240.md) | [83.6](/filings/0001628280-24-036279.md) | [86.7](/filings/0001628280-24-046438.md) | [71.1](/filings/0001824502-26-000019.md) | [67.4](/filings/0001628280-25-024755.md) | [78.8](/filings/0001628280-25-039622.md) | [93.0](/filings/0001824502-25-000010.md) | [104](/filings/0001824502-26-000059.md) | [105](/filings/0001824502-26-000038.md) | [161](/filings/0001824502-26-000059.md) |
| Total liabilities | $m | [175](/filings/0001628280-23-038275.md) | [187](/filings/0001628280-25-008823.md) | [132](/filings/0001628280-24-022240.md) | [150](/filings/0001628280-24-036279.md) | [184](/filings/0001628280-24-046438.md) | [249](/filings/0001824502-26-000019.md) | [203](/filings/0001628280-25-024755.md) | [257](/filings/0001628280-25-039622.md) | [245](/filings/0001824502-25-000010.md) | [263](/filings/0001824502-26-000059.md) | [243](/filings/0001824502-26-000038.md) | [299](/filings/0001824502-26-000059.md) |
| Long-term debt | $m | [0.0](/filings/0001628280-23-038275.md) | [7.2](/filings/0001628280-25-008823.md) | [18.1](/filings/0001628280-24-022240.md) | [32.7](/filings/0001628280-24-036279.md) | [64.0](/filings/0001628280-24-046438.md) | [64.0](/filings/0001824502-26-000019.md) | [64.1](/filings/0001628280-25-024755.md) | not reported | not reported | [79.5](/filings/0001824502-26-000059.md) | [78.8](/filings/0001824502-26-000038.md) | [78.0](/filings/0001824502-26-000059.md) |
| Current portion of debt | $m | [2.3](/filings/0001628280-23-038275.md) | [0.0](/filings/0001628280-25-008823.md) | [0.0](/filings/0001628280-24-022240.md) | [0.0](/filings/0001628280-24-036279.md) | [0.0](/filings/0001628280-24-046438.md) | [0.0](/filings/0001824502-26-000019.md) | [0.0](/filings/0001628280-25-024755.md) | not reported | not reported | [0.8](/filings/0001824502-26-000059.md) | [1.4](/filings/0001824502-26-000038.md) | [2.1](/filings/0001824502-26-000059.md) |
| Shareholders' equity | $m | [365](/filings/0001628280-24-046438.md) | [367](/filings/0001824502-26-000019.md) | [379](/filings/0001824502-25-000010.md) | [334](/filings/0001824502-25-000010.md) | [468](/filings/0001824502-25-000010.md) | [753](/filings/0001824502-26-000038.md) | [1,011](/filings/0001824502-26-000038.md) | [1,681](/filings/0001824502-25-000010.md) | [1,654](/filings/0001824502-25-000010.md) | [2,203](/filings/0001824502-26-000059.md) | [2,079](/filings/0001824502-26-000038.md) | [1,892](/filings/0001824502-26-000059.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(66.8) d](/filings/0001628280-24-046438.md) | [(84.0) d](/filings/0001824502-26-000019.md) | [(86.5)](/filings/0001628280-25-024755.md) | [(80.5) d](/filings/0001628280-25-039622.md) | [(97.2) d](/filings/0001824502-25-000010.md) | [(104) d](/filings/0001824502-26-000019.md) | [(94.6)](/filings/0001824502-26-000038.md) | [(103) d](/filings/0001824502-26-000059.md) | [(106) d](/filings/0001824502-25-000010.md) | [(129) d](/filings/0001824502-26-000019.md) | [(149)](/filings/0001824502-26-000038.md) | [(156) d](/filings/0001824502-26-000059.md) |
| Capital expenditure | $m | [15.8 d](/filings/0001628280-24-046438.md) | [9.0 d](/filings/0001824502-26-000019.md) | [17.3](/filings/0001628280-25-024755.md) | [20.9 d](/filings/0001628280-25-039622.md) | [19.6 d](/filings/0001824502-25-000010.md) | [24.2 d](/filings/0001824502-26-000019.md) | [10.0](/filings/0001824502-26-000038.md) | [18.9 d](/filings/0001824502-26-000059.md) | [20.3 d](/filings/0001824502-25-000010.md) | [29.6 d](/filings/0001824502-26-000019.md) | [32.6](/filings/0001824502-26-000038.md) | [37.1 d](/filings/0001824502-26-000059.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [240](/filings/0001628280-23-038275.md) | [247](/filings/0001628280-24-022240.md) | [251](/filings/0001628280-24-036279.md) | [278](/filings/0001628280-24-046438.md) | [320](/filings/0001628280-25-024755.md) | [334](/filings/0001628280-25-039622.md) | [398](/filings/0001824502-25-000010.md) | [540](/filings/0001824502-26-000038.md) | [579](/filings/0001824502-26-000059.md) | [661](/filings/0001824502-25-000010.md) | [767](/filings/0001824502-26-000038.md) | [782](/filings/0001824502-26-000059.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 770,023,800 at 2026-08-05, from the cover of the [10-Q filed 2026-08-10](/filings/0001824502-26-000059.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.